Tandem Diabetes Care Inc
NASDAQ:TNDM

Watchlist Manager
Tandem Diabetes Care Inc Logo
Tandem Diabetes Care Inc
NASDAQ:TNDM
Watchlist
Price: 30.81 USD 0.23% Market Closed
Market Cap: 2B USD
Have any thoughts about
Tandem Diabetes Care Inc?
Write Note

Intrinsic Value

TNDM's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one TNDM stock under the Base Case scenario is 45.81 USD. Compared to the current market price of 30.81 USD, Tandem Diabetes Care Inc is Undervalued by 33%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TNDM Intrinsic Value
45.81 USD
Undervaluation 33%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Tandem Diabetes Care Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for TNDM cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about TNDM?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Tandem Diabetes Care Inc

Provide an overview of the primary business activities
of Tandem Diabetes Care Inc.

What unique competitive advantages
does Tandem Diabetes Care Inc hold over its rivals?

What risks and challenges
does Tandem Diabetes Care Inc face in the near future?

Has there been any significant insider trading activity
in Tandem Diabetes Care Inc recently?

Summarize the latest earnings call
of Tandem Diabetes Care Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Tandem Diabetes Care Inc.

Provide P/S
for Tandem Diabetes Care Inc.

Provide P/E
for Tandem Diabetes Care Inc.

Provide P/OCF
for Tandem Diabetes Care Inc.

Provide P/FCFE
for Tandem Diabetes Care Inc.

Provide P/B
for Tandem Diabetes Care Inc.

Provide EV/S
for Tandem Diabetes Care Inc.

Provide EV/GP
for Tandem Diabetes Care Inc.

Provide EV/EBITDA
for Tandem Diabetes Care Inc.

Provide EV/EBIT
for Tandem Diabetes Care Inc.

Provide EV/OCF
for Tandem Diabetes Care Inc.

Provide EV/FCFF
for Tandem Diabetes Care Inc.

Provide EV/IC
for Tandem Diabetes Care Inc.

Show me price targets
for Tandem Diabetes Care Inc made by professional analysts.

What are the Revenue projections
for Tandem Diabetes Care Inc?

How accurate were the past Revenue estimates
for Tandem Diabetes Care Inc?

What are the Net Income projections
for Tandem Diabetes Care Inc?

How accurate were the past Net Income estimates
for Tandem Diabetes Care Inc?

What are the EPS projections
for Tandem Diabetes Care Inc?

How accurate were the past EPS estimates
for Tandem Diabetes Care Inc?

What are the EBIT projections
for Tandem Diabetes Care Inc?

How accurate were the past EBIT estimates
for Tandem Diabetes Care Inc?

Compare the revenue forecasts
for Tandem Diabetes Care Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Tandem Diabetes Care Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Tandem Diabetes Care Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Tandem Diabetes Care Inc compared to its peers.

Compare the P/E ratios
of Tandem Diabetes Care Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Tandem Diabetes Care Inc with its peers.

Analyze the financial leverage
of Tandem Diabetes Care Inc compared to its main competitors.

Show all profitability ratios
for Tandem Diabetes Care Inc.

Provide ROE
for Tandem Diabetes Care Inc.

Provide ROA
for Tandem Diabetes Care Inc.

Provide ROIC
for Tandem Diabetes Care Inc.

Provide ROCE
for Tandem Diabetes Care Inc.

Provide Gross Margin
for Tandem Diabetes Care Inc.

Provide Operating Margin
for Tandem Diabetes Care Inc.

Provide Net Margin
for Tandem Diabetes Care Inc.

Provide FCF Margin
for Tandem Diabetes Care Inc.

Show all solvency ratios
for Tandem Diabetes Care Inc.

Provide D/E Ratio
for Tandem Diabetes Care Inc.

Provide D/A Ratio
for Tandem Diabetes Care Inc.

Provide Interest Coverage Ratio
for Tandem Diabetes Care Inc.

Provide Altman Z-Score Ratio
for Tandem Diabetes Care Inc.

Provide Quick Ratio
for Tandem Diabetes Care Inc.

Provide Current Ratio
for Tandem Diabetes Care Inc.

Provide Cash Ratio
for Tandem Diabetes Care Inc.

What is the historical Revenue growth
over the last 5 years for Tandem Diabetes Care Inc?

What is the historical Net Income growth
over the last 5 years for Tandem Diabetes Care Inc?

What is the current Free Cash Flow
of Tandem Diabetes Care Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Tandem Diabetes Care Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Tandem Diabetes Care Inc

Current Assets 752.8m
Cash & Short-Term Investments 473.3m
Receivables 107.2m
Other Current Assets 172.3m
Non-Current Assets 204.9m
PP&E 168.5m
Other Non-Current Assets 36.4m
Current Liabilities 259.3m
Accounts Payable 48.8m
Accrued Liabilities 89m
Other Current Liabilities 121.5m
Non-Current Liabilities 460.7m
Long-Term Debt 307.8m
Other Non-Current Liabilities 152.9m
Efficiency

Earnings Waterfall
Tandem Diabetes Care Inc

Revenue
854.4m USD
Cost of Revenue
-428.9m USD
Gross Profit
425.4m USD
Operating Expenses
-559m USD
Operating Income
-133.6m USD
Other Expenses
6.8m USD
Net Income
-126.8m USD

Free Cash Flow Analysis
Tandem Diabetes Care Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

TNDM Profitability Score
Profitability Due Diligence

Tandem Diabetes Care Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
Positive 1-Year Revenue Growth
26/100
Profitability
Score

Tandem Diabetes Care Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

TNDM Solvency Score
Solvency Due Diligence

Tandem Diabetes Care Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Average D/E
51/100
Solvency
Score

Tandem Diabetes Care Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TNDM Price Targets Summary
Tandem Diabetes Care Inc

Wall Street analysts forecast TNDM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TNDM is 54.42 USD with a low forecast of 18.18 USD and a high forecast of 78.75 USD.

Lowest
Price Target
18.18 USD
41% Downside
Average
Price Target
54.42 USD
77% Upside
Highest
Price Target
78.75 USD
156% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for TNDM?

Click here to dive deeper.

Dividends

Tandem Diabetes Care Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TNDM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

TNDM Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

TNDM News

Other Videos

Profile

Tandem Diabetes Care Inc Logo
Tandem Diabetes Care Inc

Country

United States of America

Industry

Health Care

Market Cap

2B USD

Dividend Yield

0%

Description

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. The company is headquartered in San Diego, California and currently employs 2,000 full-time employees. The company went IPO on 2013-11-13. The firm is focused on the design, development, and commercialization of technology solutions for people living with diabetes. The firm's manufacturing, sales, and support activities principally focus on its flagship pump platform, the t:slim X2, and its complementary product offerings. Its t:slim X2 is based on Company's technology platform and is the smallest durable insulin pump available in the United States. The firm has commercially offered two different automated insulin dosing (AID) algorithms on t:slim X2, including Control-IQ technology, which is an advanced hybrid-closed loop feature, designed to help increase a user's time in their targeted glycemic range, and Food and Drug Administration (FDA) to deliver automatic correction boluses in addition to adjusting insulin to help prevent high and low blood sugar based on continuous glucose monitoring (CGM) readings.

Contact

CALIFORNIA
San Diego
11075 Roselle St
+18583666900.0
www.tandemdiabetes.com

IPO

2013-11-13

Employees

2 000

Officers

President, CEO & Director
Mr. John F. Sheridan
Executive VP, CFO & Treasurer
Ms. Leigh A. Vosseller
Executive VP & Chief Administrative Officer
Ms. Susan M. Morrison
Transitional Advisor
Mr. David B. Berger Esq.
Executive Vice President and Chief Strategy & Product Officer
Ms. Elizabeth Anne Gasser
Executive VP & Chief Commercial Officer
Mr. Mark Novara
Show More
Executive VP & COO
Mr. Jean-Claude E. Kyrillos
Chief Technical Officer
Mr. Rick A. Carpenter
Executive VP, Chief Legal, Privacy & Compliance Officer and Secretary
Ms. Shannon M. Hansen
Chief Human Resources Officer
Mr. Tom Fox
Show Less

See Also

Discover More
What is the Intrinsic Value of one TNDM stock?

The intrinsic value of one TNDM stock under the Base Case scenario is 45.81 USD.

Is TNDM stock undervalued or overvalued?

Compared to the current market price of 30.81 USD, Tandem Diabetes Care Inc is Undervalued by 33%.

Back to Top